Trials / Not Yet Recruiting
Not Yet RecruitingNCT06546059
Gasdermin D Expression in Generalized Vitiligo Patients After Narrow-band Ultraviolet B Therapy
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- South Valley University · Academic / Other
- Sex
- All
- Age
- 10 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to: 1. Evaluate the role of tissue Gasdermin D expression using immunehistochemstry techniques in patients with generalized vitiligo and compare it with healthy controls. 2. Evaluation expression of tissue Gasdermin D using immunehistochemstry techniques in patients with generalized vitiligo after narrow band ultraviolet B therapy. 3. Determine whether there is a relationship between Gasdermin D levels and disease duration and involved body surface area (VISA) in vitiligo patients.
Detailed description
The aim of this study is to: 1. Evaluate the role of tissue Gasdermin D expression using immunehistochemstry techniques in patients with generalized vitiligo and compare it with healthy controls. 2. Evaluation expression of tissue Gasdermin D using immunehistochemstry techniques in patients with generalized vitiligo after narrow band ultraviolet B therapy. 3. Determine whether there is a relationship between Gasdermin D levels and disease duration and involved body surface area (VISA) in vitiligo patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | narrow band ultraviolet-B | vitiligo patients will recevie twice sessions per week |
Timeline
- Start date
- 2024-08-01
- Primary completion
- 2024-10-01
- Completion
- 2024-11-01
- First posted
- 2024-08-09
- Last updated
- 2024-08-09
Source: ClinicalTrials.gov record NCT06546059. Inclusion in this directory is not an endorsement.